Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug compound is Brilacidin, which is in Phase II study for the treatment of oral mucositis, inflammatory bowel disease, and acute bacterial skin and skin structure infection. It also develops Prurisol, a Phase IIb compound, which is in development for psoriasis; and Kevetrin, a lead anti-cancer compound for treating ovarian cancer. In addition, the company owns other candidates for treating diseases, including autism, arthritis, asthma, MS/ALS/Parkinson's, cancer, hypertensive emergency, and bacterial and fungal infections. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Beverly, Massachusetts.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Phone(978) 236-8717
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees8
Next Earnings DateN/A
OptionableNot Optionable
Innovation Pharmaceuticals (OTCMKTS:IPIX) Frequently Asked Questions
What is Innovation Pharmaceuticals' stock symbol?
Innovation Pharmaceuticals trades on the OTCMKTS under the ticker symbol "IPIX."
Has Innovation Pharmaceuticals been receiving favorable news coverage?
Media headlines about IPIX stock have trended extremely negative on Tuesday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innovation Pharmaceuticals earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Innovation Pharmaceuticals.
Who are some of Innovation Pharmaceuticals' key competitors?
Some companies that are related to Innovation Pharmaceuticals include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG), Creative Medical Technology (CELZ) and Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (CYCCP).
What other stocks do shareholders of Innovation Pharmaceuticals own?
Who are Innovation Pharmaceuticals' key executives?
Innovation Pharmaceuticals' management team includes the folowing people:
- Mr. Leo Ehrlich, Chairman, CEO, CFO, Principal Accounting Officer & Sec. (Age 61)
- Dr. Arthur Peter Bertolino, Pres, Chief Medical Officer & Director (Age 64)
- Ms. Jane Harness, Sr. VP of Clinical Sciences & Portfolio Management (Age 51)
- Dr. W. James Alexander M.D., MPH, FACP, Consultant (Age 69)
- Dr. Paul Ginsburg, Scientific Advisor & Member of Advisory Board
How do I buy shares of Innovation Pharmaceuticals?
Shares of IPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innovation Pharmaceuticals' stock price today?
One share of IPIX stock can currently be purchased for approximately $0.1848.
What is Innovation Pharmaceuticals' official website?
How can I contact Innovation Pharmaceuticals?
Innovation Pharmaceuticals' mailing address is 100 Cummings Ctr Ste 151b, BEVERLY, MA 01915-6117, United States. The company can be reached via phone at (978) 236-8717.
MarketBeat Community Rating for Innovation Pharmaceuticals (OTCMKTS IPIX)
MarketBeat's community ratings are surveys of what our community members think about Innovation Pharmaceuticals and other stocks. Vote "Outperform" if you believe IPIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
